When practice owners start thinking about selling, one of the first questions they ask is: “What’s my practice worth?” The answer depends on a handful of factors – and understanding how they work together puts you in a much stronger negotiating position.
The EBITDA foundation
Almost every buyer in today’s healthcare M&A market values practices using EBITDA – Earnings Before Interest, Taxes, Depreciation, and Amortization. It’s the most consistent measure of what your practice actually earns as a business, independent of how you’ve structured debt or compensation.
EBITDA starts with net income, then adds back interest payments, tax obligations, depreciation on equipment and improvements, and amortization of intangibles. The result is a number that lets buyers compare practices across different ownership structures and markets on an apples-to-apples basis.
How multiples work
Once EBITDA is established, buyers apply a multiple to arrive at an enterprise value. In healthcare practice M&A, multiples typically range from 2x to 7x EBITDA depending on the specialty, market, practice size, and quality of earnings.
A multiple isn’t arbitrary. It reflects how much risk the buyer is taking on, how much growth potential exists, and how transferable the practice’s revenue is. A practice that depends heavily on a single provider commands a lower multiple. A practice with strong mid-level production, diversified revenue, and documented systems commands more.
What drives the multiple up or down
Two practices with identical EBITDA can receive very different offers. Here’s what actually moves the needle:
- Provider diversification – revenue distributed across multiple providers, not concentrated in one
- Revenue growth trend – year-over-year increases signal health; declines raise flags
- Payer mix – commercial-heavy practices are more valuable than those with high government or Medicaid exposure
- Service mix – specialty services and cash-pay revenue often carry premium valuations
- Location and market – urban and suburban markets with strong household income attract more buyers
- EBITDA margin – practices running 20%+ margins are more attractive than those at 15%
- Owner transition flexibility – owners willing to stay 2-4 years post-close command better terms
- Practice reputation – online reviews, referral networks, and community presence all factor in
A tale of two practices
Consider two practices, both generating $500,000 in EBITDA. Practice A has three providers, 80% commercial payer mix, five-year revenue growth, and two mid-level providers producing independently. Practice B has one physician owner producing 70% of revenue, flat growth over three years, and a mixed payer environment.
Practice A might receive offers in the $3M to $3.5M range. Practice B, with the same EBITDA, might see $2M to $2.5M. The difference isn’t the earnings – it’s the risk profile and growth story buyers are paying for.
The valuation process
A proper valuation analysis does more than run the numbers. It identifies the add-backs that increase your adjusted EBITDA, positions your practice’s strengths relative to buyer priorities, and flags any issues worth addressing before going to market.
Most practice owners are pleasantly surprised by their adjusted EBITDA once a qualified advisor walks through the exercise. Owner compensation, one-time expenses, personal vehicle costs, and other discretionary items often run through the practice in ways that reduce apparent earnings without reflecting the actual cash-generating power of the business.
Understanding your practice valuation options – from a quick calculator estimate to a full Opinion of Value – helps you decide what level of analysis makes sense for your situation before going to market.
Building value before you sell
The practices that receive the best offers aren’t just profitable – they’re positioned well. That means clean financials, documented systems, diversified production, and a clear story about why the revenue is sustainable and transferable.
If you’re thinking about a transition in the next 1-3 years, the conversation is worth having now. There’s usually more you can do to improve your position than you might expect.
Reach out to start a confidential conversation about what your practice could be worth in today’s market.
Frequently asked questions
What is EBITDA and why do buyers use it?
EBITDA – Earnings Before Interest, Taxes, Depreciation, and Amortization – is the standard measure buyers use to evaluate healthcare practice profitability. It strips out financing decisions and accounting treatments to show the true cash-generating power of the business, allowing comparisons across different practice structures.
What multiple should I expect on my practice?
Multiples in healthcare M&A range from 2x to 7x EBITDA depending on specialty, size, payer mix, provider concentration, and growth trajectory. Dental practices in today’s market typically see 5-7x. Dermatology and MedSpa transactions have seen higher multiples for well-positioned practices. An advisor can give you a realistic range based on current market activity in your specialty.
How much does provider concentration affect my valuation?
Significantly. When more than 60% of revenue runs through a single provider – especially the owner – buyers see key person risk and reduce their offer accordingly. Building mid-level production before going to market is one of the highest-ROI steps you can take to improve valuation.
Should I wait for the market to improve before selling?
Market timing is rarely the most important variable. The quality and positioning of your practice matters more than the macro environment. If your financials are strong and you’re within 1-5 years of wanting to transition, the better question is whether you’re positioned to receive the best offer the market will bear – not whether the market is at peak.
